Login
$NMRA
$0.40 +$0.03 (7.63%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Joshua Pinto Also a director
President & CEO
Title from the Form 4 dated Aug 20, 2026
42 Since 2025
1 year
$6,743,238
Paul L. Berns Also a director
See Remarks
Title from the Form 4 dated Aug 20, 2026
59 Not stated $4,562,461
Jason Duncan
See Remarks
Title from the Form 4 dated Aug 20, 2026
52 Not stated Not reported
Daljit (Bill) Singh Aurora
See Remarks
Title from the Form 4 dated Aug 20, 2026
58 Not stated Not reported
Michael Milligan
See Remarks
Title from the Form 4 dated Aug 20, 2026
54 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 17, 2026 · updated by the 8-K of Aug 14, 2026

Directors
7
serving now
Independent
0 of 1
stated in the proxy; 6 not stated
Average tenure
5.0 years
from year joined
CEO also chairs the board
No
Paul L. Berns
Director Age On board Independent Committees Other public boards 2025 pay Source
Paul L. Berns
59 2020
6 years
Not independent None stated None stated Not stated
Matthew Fust
61 2020
6 years
Not stated None stated None stated $134,257
David Piacquad
69 2023
3 years
Not stated
Audit Committee
None stated $97,382
Kristina Burow
52 2020
6 years
Not stated None stated Boundless Bio, Beam Therapeutics, Scholar Rock $111,132
Alaa Halawa
43 2022
4 years
Not stated None stated None stated $106,132
Maykin Ho
73 2021
5 years
Not stated
Audit Committee
Agios Pharmaceuticals, BioMarin Pharmaceutical, FibroGen Not stated
Joshua Pinto Joined Aug 14, 2026
- - - - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 17, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support